US6323071042

Podrobnosti o dividendah

Razumevanje dividendnih izplačil od Natera

Dividende od Natera so del dobička podjetja, ki se izplača delničarjem. So ključen kazalec finančnega zdravja podjetja in privlačnosti za vlagatelje. Dividende vlagateljem nudijo stalni vir dohodka, poleg dobičkov, ki se lahko pridobijo s prodajo delnice po višji ceni od nakupne.

Primerjava iz leta v leto

Proučevanje dividendnih izplačil od Natera čez leta lahko izpostavi donosnost in stabilnost podjetja. Konstantna ali naraščajoča dividendna izplačila lahko kažejo na finančno zdravo podjetje s predvidljivimi dobički, medtem ko lahko nihanje ali znižanja dividend nakazujejo na obstoječe finančne ali operativne izzive.

Vplivi na investicije

Izplačila dividend od Natera so ključni dejavnik za vlagatelje, ki so usmerjeni na dohodek. Močno izplačilo dividend lahko poveča privlačnost delnice in zagotovi redni dohodek poleg morebitnih kapitalskih dobičkov. Lahko tudi pokaže zaupanje podjetja v svoje prihodnje dobičke in je tako pomemben dejavnik pri odločitvah o naložbah.

Interpretacija nihanj dividend

Spremembe v dividendah od Natera lahko nastopijo zaradi sprememb v dobičkih podjetja, finančni politiki ali strategijah reinvestiranja. Povečanje dividend pogosto signalizira finančno stabilnost, medtem ko znižanje lahko nakazuje na potrebo po ohranjanju denarnih sredstev ali reinvestiranju dobičkov za spodbujanje rasti, pri čemer ima vsak scenarij različne posledice za vlagatelje.

Natera Aktienanalyse

Kaj počne Natera?

Natera Inc. is an American company headquartered in San Carlos, California. It was founded in 2004 by Matthew Rabinowitz and has been listed on the NASDAQ under the ticker symbol "NTRA" since 2015. The company is a leading provider of diagnostic tests and analyses and specializes in genetic analysis and diagnostic technologies. Natera specializes in tests for various medical areas, particularly in oncology diagnostics. The company's vision is to improve the quality of life for millions of people worldwide by offering innovative diagnostic tests to detect diseases early and ensure optimal treatment. Natera offers a wide range of products tailored to the needs of consumers, physicians, and scientists. The company operates in three business areas: 1) Women's Health: Natera offers tests for women and couples to determine the risk of hereditary diseases. For example, the company offers a test that allows analysis of fetal DNA from the mother's blood, allowing detection of genetic abnormalities in the fetus before birth. Additionally, Natera offers the Panorama test, which provides tests for genetic anomalies in unborn babies that can be used to determine the risk for chromosomal abnormalities and genetic mutations. 2) Oncology: In the field of oncology, Natera offers a wide range of diagnostic tests targeting developments and trends in cancer research. The tests aim to enable accurate diagnosis and prognosis, as well as provide individualized treatment for each patient. The company offers tests that assess the current tumor growth and metastatic potential, enable determination of tumor burden in cells, and provide tests for specific mutations required for determining optimal treatment. 3) Genomic Analysis: In the field of genomic analysis, Natera offers a broad range of tests available to researchers and scientists. This includes genetic variants and biological mechanisms that cause diseases. The company is also committed to developing its tests through artificial intelligence (AI) and machine learning. The goal is to provide more accurate and faster results, improve clinical decisions, and advance research and development of new diagnostics. Conclusion: Natera is a leading company in the field of diagnostic tests and analyses in the field of genomic analysis. The company has a long history of research and development of innovative product solutions for the medical community. One important focus of the company is to improve women's health and be able to detect risks for genetic diseases early; the other focus is on oncology diagnostic tools to determine optimal treatment for cancer patients. The company is constantly striving to further develop its tests and integrate new research findings and technologies to support the medical science community. Natera je eno izmed najbolj priljubljenih podjetij na Eulerpool.com.

Pogosta vprašanja o delnici Natera

Koliko dividende izplača Natera?

V zadnjih 12 mesecih je Natera izplačal dividendo v višini . To ustreza približni donosnosti dividend . V prihajajočih 12 mesecih bo Natera predvidoma izplačal dividendo v višini 0 USD.

Kakšen je donos dividend od Natera?

Trenutni donos od dividend za Natera znaša .

Kdaj Natera izplača dividend?

Natera izplačuje četrtletno dividendo. Ta se izplačuje v mesecih .

Kako varna je dividenda od Natera?

Natera je v zadnjih 0 letih vsako leto izplačeval dividend.

Kakšna je dividenda od Natera?

V naslednjih 12 mesecih se pričakuje dividende v višini 0 USD. To ustreza dividendnemu donosu 0 %.

V katerem sektorju se nahaja Natera?

Natera je razvrščen v sektor 'Zdravje'.

Wann musste ich die Aktien von Natera kaufen, um die vorherige Dividende zu erhalten?

Da si prejel zadnjo dividendo Natera z dne 20. 9. 2024 v višini 0 USD, si moral imeti delnico v depoju pred dnevom brez pravice do dividende (Ex-Tag) 20. 9. 2024.

Kdaj je Natera izplačal zadnjo dividendo?

Zadnje izplačilo dividende je bilo 20. 9. 2024.

Kakšna je bila dividenda od Natera v letu 2023?

V letu 2023 je Natera 0 USD izplačal kot dividende.

V kateri valuti Natera izplača dividendo?

Dividende od Natera se izplačujejo v USD.

Natera Dividenda 2024

Natera Dividenda

Natera Donosnost dividend

Simbol

ISIN

WKN

Koliko dividende izplača Natera 2024?

Zgodovinske Natera dividende

Je Natera dividenda varna?